Phase II study of three days' fractionated dosage of ifosfamide, epirubicin and cisplatin in small cell lung cancer

Saved in:
Bibliographic Details
Main Authors: Thongprasert S., Phromwas N., Atikachi B., Jiemsripong K.
Format: Clinical Trial
Language:English
Published: 2014
Online Access:http://www.ncbi.nlm.nih.gov/pubmed/3502482
http://cmuir.cmu.ac.th/handle/6653943832/3509
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University
Language: English
id th-cmuir.6653943832-3509
record_format dspace
spelling th-cmuir.6653943832-35092014-08-30T02:34:58Z Phase II study of three days' fractionated dosage of ifosfamide, epirubicin and cisplatin in small cell lung cancer Thongprasert S. Phromwas N. Atikachi B. Jiemsripong K. 2014-08-30T02:34:58Z 2014-08-30T02:34:58Z 1994 Clinical Trial 0284-186X 7917373 http://www.ncbi.nlm.nih.gov/pubmed/3502482 http://cmuir.cmu.ac.th/handle/6653943832/3509 eng
institution Chiang Mai University
building Chiang Mai University Library
country Thailand
collection CMU Intellectual Repository
language English
format Clinical Trial
author Thongprasert S.
Phromwas N.
Atikachi B.
Jiemsripong K.
spellingShingle Thongprasert S.
Phromwas N.
Atikachi B.
Jiemsripong K.
Phase II study of three days' fractionated dosage of ifosfamide, epirubicin and cisplatin in small cell lung cancer
author_facet Thongprasert S.
Phromwas N.
Atikachi B.
Jiemsripong K.
author_sort Thongprasert S.
title Phase II study of three days' fractionated dosage of ifosfamide, epirubicin and cisplatin in small cell lung cancer
title_short Phase II study of three days' fractionated dosage of ifosfamide, epirubicin and cisplatin in small cell lung cancer
title_full Phase II study of three days' fractionated dosage of ifosfamide, epirubicin and cisplatin in small cell lung cancer
title_fullStr Phase II study of three days' fractionated dosage of ifosfamide, epirubicin and cisplatin in small cell lung cancer
title_full_unstemmed Phase II study of three days' fractionated dosage of ifosfamide, epirubicin and cisplatin in small cell lung cancer
title_sort phase ii study of three days' fractionated dosage of ifosfamide, epirubicin and cisplatin in small cell lung cancer
publishDate 2014
url http://www.ncbi.nlm.nih.gov/pubmed/3502482
http://cmuir.cmu.ac.th/handle/6653943832/3509
_version_ 1681420061641801728